Literature DB >> 6361982

Bone formation in demineralized bone transplants treated with biosynthetic human growth hormone.

J Wittbjer, M Rohlin, K G Thorngren.   

Abstract

The influence of local administration of biosynthetic human growth hormone on the bone formation in a rabbit bone defect grafted with demineralized autologous bone was studied and compared to contralateral saline administration. The growth hormone was produced by hybrid DNA-technique and administered locally to the bone defect with the demineralized bone implant by an osmotic pump delivering 5 microliters/h during 14 days. At 14 and 28 days after operation the bone forming process was evaluated by roentgenography, planimetry included, and scintigraphy after injection of 99Tcm-labelled DPD. At 28 days after operation also autoradiography was performed. The roentgenographic and scintigraphic examinations revealed no influence from growth hormone neither 14 nor 28 days postoperatively. Centrally in the remineralized grafts the roentgenograms 28 days after operation showed radiolucent areas which in corresponding autoradiograms showed no uptake of 99Tcm. These areas turned out to be remnants of matrix. It is suggested that growth hormone has no influence on the bone induction process during the first 14 days when administered to bone matrix, probably due to relative lack of osteogenic cells. This study contributes a base for further evaluation of factors pertinent to hormonal stimulation of bone matrix transplants.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6361982     DOI: 10.3109/02844318309013105

Source DB:  PubMed          Journal:  Scand J Plast Reconstr Surg        ISSN: 0036-5556


  2 in total

1.  Composite grafts of demineralized compact bone and marrow under systemic biosynthetic growth hormone treatment.

Authors:  J Wittbjer; P Aspenberg; K G Thorngren
Journal:  Arch Orthop Trauma Surg       Date:  1985

2.  Bacterial controlled mitigation of dysbiosis in a seaweed disease.

Authors:  Jiasui Li; Marwan E Majzoub; Ezequiel M Marzinelli; Zhicong Dai; Torsten Thomas; Suhelen Egan
Journal:  ISME J       Date:  2021-08-02       Impact factor: 10.302

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.